Regeneron Pharmaceuticals, Inc.
Compositions for the treatment of rheumatoid arthritis and methods of using same

Abstract:

The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.